Mutations in the coding regions of the hepatocyte nuclear factor 4 alpha in Iranian families with maturity onset diabetes of the young

被引:0
作者
Seyed Morteza Taghavi
Seyedeh Seddigheh Fatemi
Houshang Rafatpanah
Rashin Ganjali
Jalil Tavakolafshari
Narges Valizadeh
机构
[1] Mashhad University of Medical Sciences,Internal Medicine Department, Ghaem Hospital & Endocrine Research Center
[2] Mashhad University of Medical Sciences,Immunogenetics Department, Immunology Research Center, Bu
[3] Bu Ali Square,Ali Research Center
[4] Ferdowsi Square,Microbiology and Virology Department, Bu
[5] Mashhad University of Medical Sciences,Ali Research Center
[6] Bu Ali Square,undefined
[7] Ferdowsi Square,undefined
来源
Cardiovascular Diabetology | / 8卷
关键词
Maturity Onset Diabetes; Fasting Blood Sugar; Oral Hypoglycemic Agent; Fast Serum Insulin; Iranian Patient;
D O I
暂无
中图分类号
学科分类号
摘要
Hepatocyte nuclear factor 4α (HNF4α) is a nuclear receptor involved in glucose homeostasis and is required for normal β cell function. Mutations in the HNF4α gene are associated with maturity onset diabetes of the young type 1 (MODY1). The aim of the present study was to determine the prevalence and nature of mutations in HNF4α gene in Iranian patients with a clinical diagnosis of MODY and their family members. Twelve families including 30 patients with clinically MODY diagnosis and 21 members of their family were examined using PCR-RFLP method and in case of mutation confirmed by sequencing techniques. Fifty age and sex matched subjects with normal fasting blood sugar (FBS) and Glucose tolerance test (GTT) were constituted the control group and investigated in the similar pattern. Single mutation of V255M in the HNF4α gene was detected. This known mutation was found in 8 of 30 patients and 3 of 21 individuals in relatives. Fifty healthy control subjects did not show any mutation. Here, it is indicated that the prevalence of HNF4α mutation among Iranian patients with clinical MODY is considerable. This mutation was present in 26.6% of our patients, but nothing was found in control group. In the family members, 3 subjects with the age of ≤25 years old carried this mutation. Therefore, holding this mutation in this range of age could be a predisposing factor for developing diabetes in future.
引用
收藏
相关论文
共 194 条
[1]  
Dominguez-Lopez A(2005)Mutations in MODY Genes are not Common Cause of Early-Onset Type 2 Diabetes in Mexican Families Journal of the Pancreas 6 238-245
[2]  
Miliar-Garcia A(2001)Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young N Engl J Med 345 971-980
[3]  
Segura-Kato YX(1996)Mutations in the hepatocyte factor-4α gene in maturity-onset diabetes of the young (MODY1) Nature 384 458-460
[4]  
Riba L(1992)Nonsense mutation in the glucokinase gene causes early-onset non insulin-dependent diabetes mellitus Nature 356 721-722
[5]  
Esparza-Lopez J(1996)Mutations in the hepatocyte factor-1 alpha gene in maturity-onset diabetes of the young (MODY3) Nature 384 455-458
[6]  
Ramirez-Jimenez S(1997)Early-onset type II diabetes mellitus (MODY4) linked to IPF Nat Genet 17 138-139
[7]  
Rodriguez-Torres M(1997)Mutations in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY Nat Genet 17 384-385
[8]  
Canizales-Quinteros S(1999)Mutations in NEUROD1 are associated with the development of type 2 diabetes Nat Genet 23 323-328
[9]  
Cabrera-Vasquez S(2008)Nine Novel Mutations in Maturity-Onset Diabetes of the Young (MODY) Candidate Genes in 22 Spanish Families The Journal of Clinical Endocrinology & Metabolism 87 2532-2539
[10]  
Fragoso-Ontiveros V(2000)Genetic and clinical characterisation of maturity-onset diabetes of the young in Spanish families Eur J Endocrinol 142 380-386